News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Secretariat is a trailblazer in applying contemporary financial theory to a broad spectrum of securities-related issues and financial disputes. We are highly regarded for our use of sophisticated and widely accepted statistical methodologies within financial and securities litigation and for the kind of comprehensive understanding of financial markets required in resolving disputes.
Our team of economists and securities experts regularly provides advisory services, litigation support, and expert testimony in complex securities and financial litigation, presenting clear and understandable analyses of market efficiency, causation, materiality, class certification, and damages. We effectively address intricate matters ranging from securities, structured finance, and derivatives to valuation, contract disputes, and consumer finance. Our evidence-driven, quantitative analysis, characterized by their rigorous methodologies, hold up to even the closest scrutiny.
Our expertise also extends to tax litigation, where we advise clients and provide testimony on matters encompassing economic impacts, economic substance, risk management, transfer pricing, and valuation.
Secretariat has assisted clients in a myriad of business, financial, and securities-related challenges, including the following and more:
The cornerstone of our methodology is ongoing and profound collaboration among experts and with our clients. Experts from various segments of Secretariat’s practice, whose unique knowledge and experience provide both insight and value, team when necessary with highly regarded external experts in various research and analytical disciplines who enhance the service we provide to clients. By fostering an environment of constant and transparent communication, we develop and execute creative and compelling solutions to our clients’ litigation challenges based on a thorough grasp of their business imperatives and objectives.
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.